Revenue for the Generic Pharmaceutical Manufacturing industry in Massachusetts is projected to rise at a rapid annualized rate of 4.8% to $1.4 billion over the five years to 2018, including growth of 3.5% in 2018 alone. Massachusetts is home to a growing number of biotechnology and pharmaceutical companies, many of which have headquarters in the state. Overall, the state serves as a major hub for biopharmaceutical research, as the Boston metropolitan area includes some of the nation's highest-ranked hospitals and universities. As a result, operators in the state have attracted significant capital financing for research and development from both private and public sources in recent years...purchase to read more.

Industry Statistics & Market Size
Revenue
$1bn
Annual Growth 13-18
4.8%
Forecast Growth 18-23
Profit
Employment
2,911
Businesses
29

Industry Threats & Opportunities

  • Operators have attracted significant capital financing for R&D from both private and public sources in recent years
  • Additional Insights for the Generic Pharmaceutical Manufacturing in Massachusetts Industry

    IBISWorld identifies 250 Key Success Factors for a business.The most important for the Generic Pharmaceutical Manufacturing in Massachusetts Industry are

  • Control of distribution arrangements
  • Degree of globalization
  • Undertaking generic pharmaceutical and medicine research and development
  • IBISWorld analysts also discuss how external factors such as Federal funding for Medicare and Medicaid and Number of people with private health insurance in the Generic Pharmaceutical Manufacturing in Massachusetts industry impact industry performance..

    shopping_cartPURCHASE OPTIONS

    What's in this report

    What is the Generic Pharmaceutical Manufacturing in Massachusetts Industry?

    Generic pharmaceutical and medicine manufacturers develop prescription and over-the-counter drug products that are used to prevent or treat illnesses in humans or animals. Generic drugs are produced and distributed without patent protection, and industry operators are not significantly engaged in the research and development of new drugs. The industry does not include manufacturers of nutritional supplements or cosmetic beauty products.

    Industry Products
  • Neurology
  • Infections
  • Sensory
  • Musculoskeletal
  • Immunology
  • Oncology
  • All other
  • Industry Activities
  • Developing and producing generic drugs
  • Marketing and distributing generic drugs
  • Gaining regulatory approval for generic drugs
  • Table of Contents

    Industry Definition
    Main Activities
    Similar Industries
    Additional Resources
    Industry Statistics Snapshot
    Industry Structure
    Executive Summary
    Executive Summary
    Key External Drivers
  • Federal funding for Medicare and Medicaid
  • Number of people with private health insurance
  • Regulation for the Generic Pharmaceutical Manufacturing industry
  • Research and development expenditure

  • Current Performance
    Industry Outlook
    Industry Life Cycle
  • Life cycle reasons
  • Chart: Benchmarking - Generic Pharmaceutical Manufacturing in Massachusetts Industry Lifecycle vs The Economy

  • Supply Chains
    Key Buying Industries
  • Drug, Cosmetic & Toiletry Wholesaling
  • Supermarkets & Grocery Stores
  • Pharmacies & Drug Stores
  • Hospitals

  • Key Selling Industries
  • Biotechnology
  • Chemical Product Manufacturing
  • Medical Device Manufacturing
  • Medical Instrument & Supply Manufacturing
  • Navigational Instrument Manufacturing
  • Soap & Cleaning Compound Manufacturing

  • Products & Services
  • Oncology
  • All other
  • Neurology
  • Infections
  • Immunology
  • Sensory
  • Musculoskeletal
  • Chart: Generic Pharmaceutical Manufacturing in Massachusetts Industry Products and Services Segmentation

  • Major Markets
  • Chain Stores
  • Nonretail
  • Mail Service
  • Independent
  • Food Stores
  • Chart: Major Market Segmentation for the Generic Pharmaceutical Manufacturing in Massachusetts Industry

  • Business Locations
    Chart: Business Locations by State
    Market Share Concentration
    Key Success Factors
    Cost Structure Benchmarks
  • Chart: Cost Structure Benchmarking – Sector vs Generic Pharmaceutical Manufacturing in Massachusetts

  • Basis of Competition
    Barriers to Entry
    Momenta Pharmaceuticals Inc., Sanofi Genzyme, Shire plc, Vertex Pharmaceuticals Inc.,
  • Table: Momenta Pharmaceuticals Inc. - financial performance
  • Table: Sanofi Genzyme - financial performance
  • Table: Shire plc - financial performance
  • Table: Vertex Pharmaceuticals Inc. - financial performance

  • Capital Intensity
  • Chart: Level of Capital Intensity for the Generic Pharmaceutical Manufacturing in Massachusetts Industry
  • Chart: Tools of the Trade: Growth Strategies for Success

  • Technology & Systems
    Revenue Volatility
  • Chart: Volatility vs Industry Growth

  • Regulation & Policy
    Industry Assistance
    Table: Industry Data for the Generic Pharmaceutical Manufacturing in Massachusetts Industry
    Includes:
  • Industry Revenue (2009-2023)
  • Establishments (2009-2023)
  • Businesses (2009-2023)
  • Employment (2009-2023)
  • Wages (2009-2023)
  • Total health expenditure (2009-2023)

  • Table: Annual Percentage Change for Key Industry Data
    Table: Key Ratios for Industry Key Data
    Abbreviated New Drug Application (Anda)
  • An application for the approval of a generic drug where manufacturers must scientifically prove that their products are bioequivalent to the brand products.
  • Authorized Generic
  • A prescription drug produced by brand pharmaceutical companies and marketed under a private label at a generic product price.
  • Biopharmaceuticals
  • A large protein molecule derived from living sources, as opposed to a chemical substance. Examples include insulin, human growth hormones and antibiotics.
  • Biosimilar
  • Versions of innovator biopharmaceutical products that follow patent and exclusivity expirations on innovator products.
  • Doughnut Hole
  • The Medicare Part D coverage gap; the difference of the initial coverage limit and the catastrophic coverage threshold.
  • Evergreening
  • The process whereby pharmaceutical companies slightly tweak the formulation of their high-profile products to avoid patent expiration.
  • New Drug Application (Nda)
  • An application filed for the approval of a new drug product. Once approved, the product may be marketed in the United States.
  • Patent Cliff
  • A phenomenon wherein revenue for brand name pharmaceuticals drop as the patents for high-profile drugs expire.
  • What Our Customers Say

    Why buy this report?

    IBISWorld’s Generic Pharmaceutical Manufacturing in Massachusetts Industry Research Report contains up-to-date data and analysis, allowing you to identify the strengths and potential weaknesses of major companies in the industry. Build your credibility with clients and prospects by sharing insights into the current and emerging trends driving their industry. Our market research gives you the tools to win new business and keep existing clients.

    IBISWorld industry market research reports enable you to:
    • Find out about key industry trends
    • Identify threats and opportunities
    • Inform your decisions for marketing, strategy and planning
    • Quickly build competitive intelligence
    This report on Generic Pharmaceutical Manufacturing in Massachusetts:
    • Provides Market Size information to assist with planning and strategic decisions.
    • Includes the necessary information to perform SWOT, PEST and STEER analysis.
    • Helps you understand market dynamics to give you a deeper understanding of industry competition and the supply chain.
    • Analyses key performance and operational metrics so that you can benchmark against your own business, that of your customers’ businesses, or your competitors’ businesses.
    The Generic Pharmaceutical Manufacturing in Massachusetts market research report includes:
    • Historical data and analysis for the key drivers of this industry
    • A five-year forecast of the market and noted trends
    • Detailed research and segmentation for the main products and markets
    • An assessment of the competitive landscape and market shares for major companies
    • And of course, much more

    IBISWorld reports on thousands of industries around the world. Our clients rely on our information and data to stay up-to-date on industry trends across all industries. With this IBISWorld Industry Research Report on Generic Pharmaceutical Manufacturing in Massachusetts, you can expect thoroughly researched, reliable and current information that will help you to make faster, better business decisions.

    Contact Us

    Want to speak to a representative? Call us.

    clear